[Retracted] Pan-Cancer Analysis of Prognostic and Immune Infiltrates for the TMEM65, Especially for the Breast Cancer

<div>(a) TMEM65 was closely correlated with the E2F_TARGETS, G2M_CHECKPOINT, MTORC1_SIGNALING, COMPLEMENT, and MYC_TARGETS_V1 pathways in the GSVA analysis. (b) The outcomes of the GSEA analysis for the TMEM65 for the breast cancer.</div>

Evidence-Based Complementary and Alternative Medicine

fig6

Figure 6

Figure 6: [Retracted] Pan-Cancer Analysis of Prognostic and Immune Infiltrates for the TMEM65, Especially for the Breast Cancer 